feed,title,long_url,short_url
Benzinga,eFFECTOR's Cancer Therapy Achieves Two Partial Responses In Early-Stage Study,https://benzinga.com/general/biotech/22/06/27560248/effectors-cancer-therapy-achieves-two-partial-responses-in-early-stage-study,https://bit.ly/3Np4ahu
Benzinga,Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients,https://benzinga.com/general/biotech/22/06/27560328/early-data-shows-biontechs-personalized-therapy-safe-in-pancreatic-cancer-patients,https://bit.ly/3xfWHuq
Benzinga,Insiders Buy Around $15M Of 2 Stocks,https://benzinga.com/trading-ideas/long-ideas/22/06/27561583/insiders-buy-around-15m-of-2-stocks,https://bit.ly/3GQh5Xj
